US FDA conducts inspection at Samsung Biologics facilities in S. Korea: Report
Seoul, May 21 (IANS) The US Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics’ production facilities in South Korea, industry sources said Wednesday. According… Continue reading US FDA conducts inspection at Samsung Biologics facilities in S. Korea: Report








